Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-29

Clinical Trial Update: Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children [Phase 3]

View source ↗

Summary

Phase 3 safety study results completed for combination vaccines Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY in children; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mencevax ACWY
  • Tritanrix-HepB/Hib-MenAC
  • Tritanrix-HepB/Hiberix

Snippet

Sponsor: GlaxoSmithKline | Conditions: Whole Cell Pertussis, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2017-03-29